Published in Prog Clin Biol Res on January 01, 1982
Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease. Am J Pathol (2003) 1.81
Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene. Proc Natl Acad Sci U S A (1985) 1.53
Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease. Proc Natl Acad Sci U S A (1985) 1.42
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring. J Inherit Metab Dis (2008) 1.41
Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease. J Biol Chem (2011) 1.13
The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). J Inherit Metab Dis (2010) 1.10
Comparison of the chromosomal localization of murine and human glucocerebrosidase genes and of the deduced amino acid sequences. Proc Natl Acad Sci U S A (1989) 0.94
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. Am J Hematol (2012) 0.90
Genetic heterogeneity in Gaucher disease. J Med Genet (1986) 0.85
Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications. Orphanet J Rare Dis (2014) 0.83
Outcome of ten years' echocardiographic follow-up in children with Gaucher disease. Eur J Pediatr (2006) 0.75
A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells. Diseases (2017) 0.75
Transformation in Pre-treatment Manifestations of Gaucher Disease Type 1 during Two Decades of Alglucerase/Imiglucerase Enzyme Replacement Therapy in the International Collaborative Gaucher Group (ICGG) Registry. Am J Hematol (2017) 0.75
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am (1971) 9.93
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med (1995) 8.15
A Drosophila RNA polymerase II transcription factor contains a promoter-region-specific DNA-binding activity. Cell (1984) 7.69
Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med (1989) 7.52
A Drosophila RNA polymerase II transcription factor binds to the regulatory site of an hsp 70 gene. Cell (1984) 7.23
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med (1991) 6.09
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1996) 4.44
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med (2000) 4.12
Sequences required for in vitro transcriptional activation of a Drosophila hsp 70 gene. Cell (1985) 4.11
Prenatal genetic diagnosis. I. N Engl J Med (1970) 3.67
Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am (1998) 3.56
Iron and the sex difference in heart disease risk. Lancet (1981) 3.45
Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect (1998) 3.27
Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am (1994) 2.93
The response of articular cartilage to mechanical injury. J Bone Joint Surg Am (1982) 2.92
Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am (1994) 2.86
Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am (1999) 2.85
Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med (1998) 2.80
Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol (1968) 2.66
The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch Intern Med (2000) 2.63
High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol (1996) 2.61
Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am (1986) 2.49
The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am (1982) 2.46
Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood (1989) 2.37
Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. HIV Med (2005) 2.33
Chondroblastoma of bone. J Bone Joint Surg Am (2000) 2.33
Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med (1992) 2.33
Immune response after splenectomy. Lancet (1978) 2.31
Prenatal genetic diagnosis (second of three parts). N Engl J Med (1970) 2.29
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am (1988) 2.24
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg Am (1970) 2.15
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis (1998) 2.08
Osteoarticular allografts for reconstruction in the proximal part of the humerus after excision of a musculoskeletal tumor. J Bone Joint Surg Am (1990) 2.08
Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J Virol (2000) 2.04
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol (2000) 2.04
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis (1995) 1.97
Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect (1998) 1.90
Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. J Virol (1989) 1.87
Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med (1975) 1.86
Influenza virus infection in nude mice. J Infect Dis (1976) 1.85
Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol (1993) 1.84
Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res (2001) 1.83
Fractures about the hip in an institutionalizedpatient population. II. Survival and ability to walk again. J Bone Joint Surg Am (1968) 1.82
Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol (2001) 1.80
Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests. N Engl J Med (1990) 1.78
Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. J Immunol (1989) 1.77
Calcific myonecrosis. A late sequela to compartment syndrome of the leg. Clin Orthop Relat Res (1995) 1.75
Articular cartilage repair and transplantation. Arthritis Rheum (1998) 1.73
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Cancer Res (1981) 1.72
Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants. J Immunol (2001) 1.72
The caudal gene product is a direct activator of fushi tarazu transcription during Drosophila embryogenesis. Nature (1989) 1.70
HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol (1995) 1.69
Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med (1999) 1.69
Massive resection and allograft transplantation in the treatment of malignant bone tumors. N Engl J Med (1976) 1.67
Desmoplastic fibroma of bone. A report of eight cases and review of the literature. J Bone Joint Surg Am (1985) 1.67
The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin Orthop Relat Res (1991) 1.66
Clinical experience with allograft implantation. The first ten years. Clin Orthop Relat Res (1983) 1.64
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature (1984) 1.63
Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrob Agents Chemother (1993) 1.62
Giant synovial cysts of the calf in patients with rheumatoid arthritis. J Bone Joint Surg Am (1968) 1.62
Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer (1985) 1.62
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol (1999) 1.61
Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol (1998) 1.59
Transcriptional control of Drosophila fushi tarazu zebra stripe expression. Genes Dev (1989) 1.58
High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J Infect Dis (1995) 1.58
Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am (1990) 1.57
Osteoid osteoma: percutaneous radio-frequency ablation. Radiology (1995) 1.57
Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys (1998) 1.56
Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease. Am J Hum Genet (1980) 1.56
The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study. J Bone Joint Surg Am (1997) 1.56
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.55
Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol (1999) 1.55
Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants. J Virol (1999) 1.54
Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. AIDS (1991) 1.53
The glycosaminoglycans of normal and arthritic cartilage. J Clin Invest (1971) 1.52
Operative treatment of sacrococcygeal chordoma. A review of twenty-one cases. J Bone Joint Surg Am (1993) 1.52
The reaction of articular cartilage to injury and osteoarthritis (second of two parts). N Engl J Med (1974) 1.51
Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses (1994) 1.51
Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection. N Engl J Med (1997) 1.50
Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease. Neurology (2000) 1.50
"Chronic Epstein-Barr virus infection" syndrome and polymyalgia rheumatica. J Rheumatol (1988) 1.50
The enzymatic formation of sphingomyelin from ceramide and lecithin in mouse liver. J Biol Chem (1974) 1.47
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med (1998) 1.47
Inhibition of lymphocyte stimulation by measles virus. J Immunol (1975) 1.47
The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities. Orthop Clin North Am (1987) 1.44
A complex bilateral polysyndactyly disease locus maps to chromosome 7q36. Nat Genet (1994) 1.44
On the antioxidant properties of erythropoietin and its association with the oxidative-nitrosative stress response to hypoxia in humans. Acta Physiol (Oxf) (2014) 1.43
The acute effects of intra-articular hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg Am (1966) 1.43
Antioxidants and coronary heart disease. Lancet (1991) 1.43
GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Am J Hum Genet (1990) 1.43
Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol (1987) 1.42
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J Infect Dis (1997) 1.41
Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med (1985) 1.41